Espansione Group, a global leader in photobiomodulation (PBM), has marked its presence with significant advancements in ophthalmology and beyond. After a decade where it has made significant strides, especially in the anterior segment of the eye, the company is now pioneering its application for the posterior pole, venturing into new territory with treatments for Age-Related Macular Degeneration (AMD), specifically in its early stages (i.e.,dry AMD).
